Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dr. Reddy's Laboratories Limited and Integra LifeSciences Holdings Corporation have entered into an exclusive distribution agreement. Under the agreement, Dr. Reddy’s will market and distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration ...
read more
Cota Healthcare, a data and technology platform for value-based precision medicine, today announced the signing of a major, multi-year collaboration with Novartis Pharmaceuticals Corporation to help improve clinical and cost outcomes for breast ...
read more
Avista Pharma Solutions, Inc has announced that the $4 million expansion of its 26,000-square foot contract testing facility in Agawam, Massachusetts is now complete. For over 30 years, the Agawam site has provided superior service to pharmaceutical ...
read more
Recipharm has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and delivery of Emla™ Patch to Japan.
read more
SGS has announced that it has invested in multiple highly sensitive and selective LC-MS/MS instruments at its Poitiers, France laboratory, for the quantification of proteins and peptide therapeutics.
read more
Piramal Pharma Solutions has announced the appointment of Stuart E. Needleman as its Chief Commercial Officer.
read more
Eurofins Scientific has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment.
read more
Cellaria, LLC has announced the expansion of its offerings to include a suite of stem cell services. The initiative advances Cellaria’s mission to provide more accurate patient and disease-specific cell models to help researchers focus and accelerate...
read more
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has announced the immediate appointment of Kirk Shepard, MD, as Senior Vice President, Global Medical Affairs of the Oncology Business Group. Dr. Shepard will be responsible for ...
read more
Upsher-Smith Laboratories has entered into an exclusive agreement with an emerging pharmaceutical company to market and distribute three generic products. These products will compete in markets with combined U.S. annual sales of nearly $200 million, ...
read more
Lonza now offers a comprehensive portfolio of fresh and cryopreserved human and animal hepatocytes for ADME-Tox testing, further strengthening its position as a leader in cell discovery.
read more
Pfizer CentreOne has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines. The service will be provided at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract ...
read more
Camargo Pharmaceutical Services has received a significant growth investment from a private non-institutional investment firm.
read more
Patheon, a global provider of pharmaceutical development and manufacturing services, has reported financial results for the quarter ended January 31, 2017.
read more
Wednesday, March 15, 2017
Callery, LLC is the new stand-alone entity formed from BASF's divestment of its Inorganic Specialties business. The divestiture was facilitated by Edgewater Capital in combination with the Callery management team. Callery is a global leader in highly...
read more